The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study
Abstract
Background: Candidemia is the most common, serious fungal infection and Candida antifungal resistance is a challenge. We report recent surveillance of candidemia in China. Methods: The study encompassed 77 Chinese hospitals over 3 years. Identification of Candida species was by mass spectrometry and DNA sequencing. Antifungal susceptibility was determined using the Clinical and Laboratory Standards Institute broth microdilution method. Results: In total, 4010 isolates were collected from candidemia patients. Although C. albicans was the most common species, non-albicans Candida species accounted for over two-thirds of isolates, predominated C. parapsilosis complex (27.1%), C. tropicalis (18.7%), and C. glabrata complex (12.0%). Most C. albicans and C. parapsilosis complex isolates were susceptible to all antifungal agents (resistance rate <5%). However, there was a decrease in voriconazole susceptibility to C. glabrata sensu stricto over the 3 years and fluconazole resistance rate in C. tropicalis tripled. Amongst less common Candida species, over one-third of C. pelliculosa isolates were coresistant to fluconazole and 5-flucytocine, and >56% of C. haemulonii isolates were multidrug resistance. Conclusions: Non-albicans Candida species are the predominant cause of candidemia in China. Azole resistance is notable amongst C. tropicalis and C. glabrata. Coresistance and multidrug resistance has emerged in less common Candida species.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Comparatively, the proportion of C. parapsilosis has increased in Asia (including Japan and China), Latin America (including Brazil) and Southern Europe,31,62–65”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [65]
In the citing paper
“The most common Candida species among them was C. albicans (32.9%), followed by C. parapsilosis (27.1%), C. tropicalis (18.7%), and C. glabrata (12.0%).8”
In the citing paper
“These results were considerably different from our results as the proportion of isolated C. albicans was 10% lower, whereas that of isolated C. parapsilosis and C. tropicalis was 10% higher compared with that observed in our study.”
In the citing paper
“However, contrary results were obtained in a national surveillance study in China that evaluated the proportion of each Candida species among 4010 candidemia isolates obtained from 77 hospitals from 2015–2017.8 According to this study, C. albicans accounted for 32.9%, C. parapsilosis for 27.1%, C. glabrata for 12.0%, and C. tropicalis for 18.7% of the isolates.”
In the citing paper
“These previous studies indicate regional differences in the distribution of Candida spp.”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
The global problem of antifungal resistance: prevalence, mechanisms, and management
Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Candida auris: a Review of the Literature
Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K., Johnson, E. M., Borman, A., Candida auris Incident Management Team, Manuel, R., & Brown, C. S. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-17 · Cited by 595
Changes in the epidemiological landscape of invasive candidiasis
Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547
Research works printed but not linked: 3
- Clinical and Laboratory Standards Institute, 2017, M27. Reference method for broth dilution antifungal susceptibility testing of yeasts
- Clinical and Laboratory Standards Institute, 2017, M60. Performance standards for antifungal susceptibility testing of yeasts
- Clinical and Laboratory Standards Institute, 2018, M59. Epidemiological cutoff values for antifungal susceptibility testing
Cited by
Branco, J., Miranda, I. M., & Rodrigues, A. G. (2023) · Journal of Fungi · doi:10.3390/jof9010080 · Cited by 164
Bretagne, S., Sitbon, K., Desnos‐Ollivier, M., Garcia‐Hermoso, D., Letscher‐Bru, V., Cassaing, S., Millon, L., Morio, F., Gangneux, J., Hasseine, L., et al. (2022) · mBio · doi:10.1128/mbio.00920-22 · Cited by 113
“Networks such as SENTRY (5) or CHIF-NET (6) provide microbiological data and others such as FungiScope (7) add clinical information.”
BackgroundEpidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Thomaz, D. Y., de Almeida, J. N., Sejas, O. N. E., Negro, G. M. B. D., Carvalho, G. O. M. H., Gimenes, V. M. F., de Souza, M. E. B., Arastehfar, A. A., Camargo, C. H., Motta, A. L., et al. (2021) · Journal of Fungi · doi:10.3390/jof7040259 · Cited by 103
Bilal, H., Shafiq, M., Hou, B., Islam, R., Khan, M. N., Khan, R. U., & Zeng, Y. (2022) · Virulence · doi:10.1080/21505594.2022.2123325 · Cited by 91
“albicans species are increasing (reported >67% in 2020), mainly due to their AFR ability [14].”
Background
Metadata
- Authors
- Xiao, M., Chen, S. C.-A., Kong, F., Xu, X.-L., Yan, L., Kong, H.-S., Fan, X., Hou, X., Cheng, J.-W., Zhou, M.-L., Li, Y., Yu, S.-Y., Huang, J.-J., Zhang, G., Yang, Y., Zhang, J.-J., Duan, S.-M., Kang, W., Wang, H., & Xu, Y.-C.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- The University of Sydney (AU)
- Laboratory Department, Xijing Hospital, Air Force Medical University, Xi’an, China
- Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
- Center of Clinical Laboratory, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China
- Department of Laboratory Medicine, Peking Union Medical College Hospital, Beijing, China
- Peking Union Medical College Hospital (CN)
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-03-16
- Volume
- 221
- Issue
- Supplement_2
- Pages
- S139-S147
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W3011942783
- Cited by
- 115
- References
- 34
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 18 · 2023: 26 · 2022: 12 · 2021: 16 · 2020: 4
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of China (81802042)
- National Major Science and Technology Project (2018ZX10712001)
- Leading Innovation-Oriented Biopharmaceutical Industry Cluster Project in Zheng-Luo-Xin National Innovation Demonstration Area (181200211900)
- Fundamental Research Funds for the Central Universities (3332018041, 3332018035)
- Outstanding Young Talents Cultivation Program in Dongcheng District
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, Candida species distribution, antifungal susceptibility, non-albicans Candida, Candida albicans, Candida parapsilosis complex, Candida tropicalis, Candida glabrata complex, voriconazole resistance, fluconazole resistance, azole resistance, multidrug resistance, co-resistance, Candida pelliculosa, Candida haemulonii
- MeSH terms
- Antifungal Agents, Azoles, Candida, China, Hospitals, Humans, Membrane Proteins, Microbial Sensitivity Tests, Sequence Analysis, DNA, Drug Resistance, Fungal, Candidemia, Epidemiological Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study. https://app.cochat.ai/papers/10.1093/infdis/jiz573
- The paper
- Xiao, M., Chen, S. C.-A., Kong, F., Xu, X.-L., Yan, L., Kong, H.-S., Fan, X., Hou, X., Cheng, J.-W., Zhou, M.-L., Li, Y., Yu, S.-Y., Huang, J.-J., Zhang, G., Yang, Y., Zhang, J.-J., Duan, S.-M., Kang, W., Wang, H., & Xu, Y.-C. (2020). Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiz573
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.